CD8A and COVID-19: Neutralizing antibodies have been identified as a correlate of protection [6]; concomitantly, a robust, timely, and coordinated adaptive CD4+ and CD8+ T-cell response may be critical for attenuating the severity of COVID-19 [1,7,8,9].